+

WO2017032859A3 - Composés pour induire la formation tissulaire et leurs utilisations - Google Patents

Composés pour induire la formation tissulaire et leurs utilisations Download PDF

Info

Publication number
WO2017032859A3
WO2017032859A3 PCT/EP2016/070136 EP2016070136W WO2017032859A3 WO 2017032859 A3 WO2017032859 A3 WO 2017032859A3 EP 2016070136 W EP2016070136 W EP 2016070136W WO 2017032859 A3 WO2017032859 A3 WO 2017032859A3
Authority
WO
WIPO (PCT)
Prior art keywords
compounds
tissue formation
inducing tissue
pep2
amino acids
Prior art date
Application number
PCT/EP2016/070136
Other languages
English (en)
Other versions
WO2017032859A2 (fr
Inventor
Omar F. ZOUANI
Original Assignee
Histide Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Histide Ag filed Critical Histide Ag
Publication of WO2017032859A2 publication Critical patent/WO2017032859A2/fr
Publication of WO2017032859A3 publication Critical patent/WO2017032859A3/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/64—Cyclic peptides containing only normal peptide links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q7/00—Preparations for affecting hair growth
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/51—Bone morphogenetic factor; Osteogenins; Osteogenic factor; Bone-inducing factor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Dermatology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

La présente invention concerne un peptide cyclique, ou un variant ou un analogue de celui-ci, ou un peptidomimétique cyclique, présentant entre 10 et 35 acides aminés, ayant une capacité de liaison au récepteur du facteur de croissance et comprenant un peptide présentant cinq acides aminés PEP2; PEP2 étant choisi dans le groupe constitué de LKNYQ, LKVYP, LKKYR, LRKHR, LKYHY, KFKYE, YGKIP, YKQYE, DHHKD, EQLSN, IGEMS, LGEMS, KEVQV et KKATV.
PCT/EP2016/070136 2015-08-25 2016-08-25 Composés pour induire la formation tissulaire et leurs utilisations WO2017032859A2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201562209425P 2015-08-25 2015-08-25
US62/209,425 2015-08-25

Publications (2)

Publication Number Publication Date
WO2017032859A2 WO2017032859A2 (fr) 2017-03-02
WO2017032859A3 true WO2017032859A3 (fr) 2017-06-01

Family

ID=56855432

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2016/070136 WO2017032859A2 (fr) 2015-08-25 2016-08-25 Composés pour induire la formation tissulaire et leurs utilisations

Country Status (1)

Country Link
WO (1) WO2017032859A2 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2021054449A1 (fr) * 2019-09-18 2021-03-25 国立大学法人 岡山大学 Production de lbm, cpc, opc, et procédés de contrôle de qualité correspondants, kit, matériau de greffe et modèle de maladie

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998054577A1 (fr) * 1997-05-28 1998-12-03 Beth Israel Deaconess Medical Center, Inc. Banque de peptides cycliques et procedes d'utilisation de ces banques pour identifier des motifs structuraux de liaison
US20030185792A1 (en) * 1996-01-22 2003-10-02 Curis, Inc. Morphogen analogs of bone morphogenic proteins
WO2005017619A1 (fr) * 2003-08-04 2005-02-24 Eastman Kodak Company Materiau d'imagerie aux proprietes mecaniques ameliorees
WO2007150053A2 (fr) * 2006-06-22 2007-12-27 Biosurface Engineering Technologies, Inc. Composition et procédé pour délivrer un amplificateur/co-activateur de la bmp-2 afin d'améliorer l'ostéogenèse
EP2615116A1 (fr) * 2010-09-10 2013-07-17 Nano Intelligent Biomedical Engineering Corporation Co., Ltd. Peptide ayant la capacité de régénérer le tissu osseux et de se lier à l'apatite
US20130303449A1 (en) * 2004-01-28 2013-11-14 United States Government Represented By The Department Of Veterans Affairs Surgical applications for bmp binding protein
WO2014140504A1 (fr) * 2013-03-14 2014-09-18 Teknimed SUBSTITUTS OSSEUX GREFFES PAR des PEPTIDES MIMETIQUES DE LA PROTEINE HUMAINE BMP-2

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030185792A1 (en) * 1996-01-22 2003-10-02 Curis, Inc. Morphogen analogs of bone morphogenic proteins
WO1998054577A1 (fr) * 1997-05-28 1998-12-03 Beth Israel Deaconess Medical Center, Inc. Banque de peptides cycliques et procedes d'utilisation de ces banques pour identifier des motifs structuraux de liaison
WO2005017619A1 (fr) * 2003-08-04 2005-02-24 Eastman Kodak Company Materiau d'imagerie aux proprietes mecaniques ameliorees
US20130303449A1 (en) * 2004-01-28 2013-11-14 United States Government Represented By The Department Of Veterans Affairs Surgical applications for bmp binding protein
WO2007150053A2 (fr) * 2006-06-22 2007-12-27 Biosurface Engineering Technologies, Inc. Composition et procédé pour délivrer un amplificateur/co-activateur de la bmp-2 afin d'améliorer l'ostéogenèse
EP2615116A1 (fr) * 2010-09-10 2013-07-17 Nano Intelligent Biomedical Engineering Corporation Co., Ltd. Peptide ayant la capacité de régénérer le tissu osseux et de se lier à l'apatite
WO2014140504A1 (fr) * 2013-03-14 2014-09-18 Teknimed SUBSTITUTS OSSEUX GREFFES PAR des PEPTIDES MIMETIQUES DE LA PROTEINE HUMAINE BMP-2

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
BEHNAM K ET AL: "BMP binding peptide: a BMP-2 enhancing factor deduced from the sequence of native bovine bone morphogenetic protein/non-collagenous protein", JOURNAL OF ORTHOPAEDIC RESEARCH, ORTHOPAEDIC RESEARCH SOCIETY, US, vol. 23, no. 1, 1 January 2005 (2005-01-01), pages 175 - 180, XP027720514, ISSN: 0736-0266, [retrieved on 20050101] *
ZOUANI O F ET AL: "Differentiation of pre-osteoblast cells on poly(ethylene terephthalate) grafted with RGD and/or BMPs mimetic peptides", BIOMATERIALS, ELSEVIER SCIENCE PUBLISHERS BV., BARKING, GB, vol. 31, no. 32, 1 November 2010 (2010-11-01), pages 8245 - 8253, XP027259529, ISSN: 0142-9612, [retrieved on 20100725] *

Also Published As

Publication number Publication date
WO2017032859A2 (fr) 2017-03-02

Similar Documents

Publication Publication Date Title
WO2017032856A3 (fr) Composés destinés à induire une formation de tissu et utilisations de ces composés
WO2017032858A3 (fr) Composés pour induire la formation tissulaire et leurs utilisations
EP3248986A3 (fr) Domaines variables d'immunoglobuline
EP4406617A3 (fr) Composition pour modification de surface
EP3363458A3 (fr) Peptide
WO2017032855A3 (fr) Composés pour induire la formation tissulaire et leurs utilisations
EP3708660A3 (fr) Polypeptides
EP4406599A3 (fr) Utilisation de variants de peptide natriurétique de type c pour traiter une dysplasie du squelette
WO2015038796A3 (fr) Sécrétion de polypeptides contenant un hème
MX2017004488A (es) Composiciones farmaceuticas que comprenden variantes peptidicos y metodos para su uso.
MY200925A (en) Peptide Amide Compound and Preparation Method and Medical use Thereof
WO2015185758A3 (fr) Préparation comprenant le facteur viii et des peptides du facteur de von willebrand
BR112012020953A2 (pt) produto, uso do mesmo, metodo para prevencao e/ou tratamento de fibrose corneana ou opacidade corneana e composicao farmaceutica oftalmica
UA118167C2 (uk) Пептид та його застосування
WO2015179635A3 (fr) Peptides inhibiteurs de ras et leurs utilisations
EP3936141A3 (fr) Composés anti-sénescence et leurs utilisations
WO2015019198A3 (fr) Compositions pharmaceutiques de pancréatine de puissance élevée
WO2017091734A3 (fr) Nouveaux peptides et leurs utilisations
WO2013021284A3 (fr) Composition de vaccin anti-il-6
WO2017032853A3 (fr) Composés destinés à induire une formation de tissu et utilisations de ces composés
WO2015110915A3 (fr) Analogues rétro-inverso de spadine à effets antidépresseurs accrus
MX2016013589A (es) Composiciones que comprenden derivados de osteopontina para la inhibicion del crecimiento de pelo.
WO2016159567A3 (fr) Composition pour favoriser la croissance capillaire ou la régénération capillaire, et à effet anti-inflammatoire
WO2017048699A3 (fr) Anticorps monoclonaux hautement puissants dirigés contre des facteurs angiogéniques
WO2016172269A3 (fr) Analogues d'insuline ayant des peptides à chaîne b raccourcie et procédés associés

Legal Events

Date Code Title Description
NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 16760426

Country of ref document: EP

Kind code of ref document: A2

点击 这是indexloc提供的php浏览器服务，不要输入任何密码和下载